Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Experts fear private equity will pour gas on cardiology’s overuse problem

Skip to the end of the Expertise Menu

Coronary stenting is, by some measures, the most overused procedure in hospitals. The problem costs the health system millions and unnecessarily exposes patients to risks of blood clots, torn arteries, infections, and other life-threatening injuries.

In 2020, Medicare started paying physicians to place stents, balloons, and perform other procedures designed to open clogged coronary arteries outside of hospitals, in less expensive outpatient settings. It didn’t take long for private equity firms to catch on. They’ve been racing to buy up cardiology practices ever since, rolling them into bigger and bigger chains with an eye toward reselling them at a profit.

Access the full article to read some thoughts from Eric Major: Experts fear private equity will pour gas on cardiology’s overuse problem

About STAT News

STAT delivers trusted and authoritative journalism about health, medicine, and the life sciences. Millions of new readers turned to us as we sounded the alarm early on about the Covid-19 pandemic. Journalists go deep in tough-minded coverage of the business of making medicines, health tech, science, and public health.

STAT takes you inside academic labs, biotech boardrooms, and political backrooms. STAT casts a critical eye on scientific discoveries, scrutinize corporate strategies, and chronicle roiling battles for talent, money, and market share. STAT examines controversies and puncture hype. With an award-winning newsroom, STAT gives you indispensable insights and exclusive stories on the technologies, personalities, power brokers, and political forces driving massive changes in the life science industry — and a revolution in human health. These are the stories that matter to us all. Visit to learn more.